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A B S T R A C T
Following exocytosis, synaptic vesicles (SVs) have to be reformed with the correct complement of proteins in the
correct stoichiometry to ensure continued neurotransmission. Synaptophysin is a highly abundant, integral SV
protein necessary for the eﬃcient retrieval of the SV SNARE protein, synaptobrevin II (sybII). However the
molecular mechanism underpinning synaptophysin-dependent sybII retrieval is still unclear. We recently iden-
tiﬁed a male patient with severe intellectual disability, hypotonia, epilepsy and callosal agenesis who has a point
mutation in the juxtamembrane region of the fourth transmembrane domain of synaptophysin (T198I). This
mutation had no eﬀect on the activity-dependent retrieval of synaptophysin that was tagged with the geneti-
cally-encoded pH-sensitive reporter (pHluorin) in synaptophysin knockout hippocampal cultures. This suggested
the mutant has no global eﬀect on SV endocytosis, which was conﬁrmed when retrieval of a diﬀerent SV cargo
(the glutamate transporter vGLUT1) was examined. However neurons expressing this T198I mutant did display
impaired activity-dependent sybII retrieval, similar to that observed in synaptophysin knockout neurons.
Interestingly this impairment did not result in an increased stranding of sybII at the plasma membrane.
Screening of known human synaptophysin mutations revealed a similar presynaptic phenotype between T198I
and a mutation found in X-linked intellectual disability. Thus this novel human synaptophysin mutation has
revealed that aberrant retrieval and increased plasma membrane localisation of SV cargo can be decoupled in
human disease.
1. Introduction
Maintaining neurotransmission is essential for normal brain com-
munication. Furthermore a large body of evidence is emerging in-
dicating that altered synaptic transmission can result in a series of
neurodegenerative and neurodevelopmental disorders (Milnerwood
and Raymond, 2010; Sheng et al., 2012; Zoghbi and Bear, 2012). In
particular synaptic dysfunction has been increasingly associated the
genesis and presentation of neurodevelopmental disorders (Wijetunge
et al., 2013; Zoghbi and Bear, 2012). The majority of these studies have
focused on postsynaptic dysfunction, however several recent studies
have highlighted presynaptic dysfunction as a potentially causal me-
chanism (Giovedi et al., 2014; Valente et al., 2016; Waites and Garner,
2011).
Presynaptic function is reliant on the accurate and eﬃcient fusion
(exocytosis) and reformation of synaptic vesicles (SVs) by endocytosis
(Jahn and Fasshauer, 2012; Saheki and De Camilli, 2012; Sudhof,
2012). Recent studies have highlighted mutations in a series of key
presynaptic genes that result in altered neurotransmitter release due to
either perturbations in the number of SVs available for fusion (Corradi
et al., 2014; Deng et al., 2011; Fassio et al., 2011; Myrick et al., 2015),
coupling of SV fusion to calcium inﬂux (Baker et al., 2015; Ferron et al.,
2014; Valente et al., 2016; Whittaker et al., 2015), or the eﬃciency of
the SV fusion event itself (Deciphering Developmental Disorders, 2015;
Saitsu et al., 2008). In addition mutations in a number of SV en-
docytosis genes have been linked to neurodevelopmental disorders
(Deciphering Developmental Disorders, 2015; Dhindsa et al., 2015;
Euro et al., 2014; Serajee and Huq, 2015) suggesting accurate SV for-
mation is equally important for normal presynaptic function.
Included in the endocytosis genes linked to neurodevelopmental
disorders is SYP, which encodes the abundant SV protein synapto-
physin. Synaptophysin is an integral SV protein with four
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transmembrane domains and cytoplasmic N- and C-termini (Sudhof
et al., 1987). It is the second most abundant protein on SVs, with the
most abundant being the essential fusion molecule synaptobrevin II
(sybII) (Takamori et al., 2006; Wilhelm et al., 2014). Synaptophysin
interacts with sybII in both mammalian brain lysates and isolated SVs.
This association is postulated to occur via their respective transmem-
brane domains (Becher et al., 1999; Edelmann et al., 1995; Felkl and
Leube, 2008; Reisinger et al., 2004; Yelamanchili et al., 2005). Neurons
from synaptophysin knockout mice display a speciﬁc defect in sybII
retrieval during SV endocytosis and an increased proportion of sybII
mislocalised to the plasma membrane, suggesting this interaction is
essential for accurate sybII traﬃcking (Gordon and Cousin, 2013;
Gordon et al., 2011). Recent structural studies suggest that synapto-
physin and sybII interact in a 1:2 ratio (Adams et al., 2015) indicating
that this interaction may control the stoichiometry of their retrieval
during SV endocytosis (Gordon et al., 2016).
A series of mutations in the SYP gene have been identiﬁed in pa-
tients with X-linked intellectual disability (Tarpey et al., 2009). These
mutations were all unable to support normal sybII retrieval when ex-
pressed in synaptophysin knockout neurons (Gordon and Cousin,
2013). Thus altered sybII retrieval due to synaptophysin dysfunction
may be a potentially common mechanism underlying speciﬁc neuro-
developmental disorders. We report here a novel SYP mutation iden-
tiﬁed in a patient with a severe neurodevelopmental disorder. This
mutation does not impact on SV endocytosis or the traﬃcking of
common SV cargoes. However it is unable to support sybII retrieval in
synaptophysin knockout neurons. Intriguingly it fully restores plasma
membrane levels of sybII, suggesting that activity-dependent traﬃcking
of sybII is speciﬁcally aﬀected by this mutation.
2. Methods
2.1. Genomic analysis of whole exome sequencing data (trio analysis)
DNA extracted from blood of the patient and both parents was en-
riched with Agilent Sureselect Clinical Research Exome (CRE) Capture
and samples were run on the Illumina HiSeq platform. As an average,
50 million reads per exome and a mapped fraction above 98% were
obtained. The average coverage is approximately 50 fold. Data were
demultiplexed by Illumina software bcl2fastq. Reads were mapped to
the genome using BWA (bio-bwa.sourceforge.net). Variant detection
was performed by Genome Analysis Toolkit (www.broadinstitute.org/
gatk). Analysis of variants was performed in Cartagenia using The
Variant Calling File (VCF) followed by ﬁltering for de novo, X-linked,
recessive and dominant inheritance in a panel of 528 genes conﬁrmed
to be involved in neurodevelopmental disorders (Gilissen et al., 2014).
The variant found in SYP (c.593C > T, p.Thr198Ile (SYP, exon 05)) on
the X chromosome, was conﬁrmed by capillary Sanger sequencing in
DNA from the patient and the mother (in heterozygosity) while was not
found in the father.
2.2. Materials
SybII-pHluorin was provided by Prof. G. Miesenbock (Oxford University,
UK). Synaptophysin-pHluorin was from Prof. Leon Lagnado (Sussex
University, UK), whereas vGLUT-pHluorin was from Prof. Robert Edwards
(University of California, USA). The T198I mutant was introduced into rat
synaptophysin-pHluorin by mutagenesis using the primers (mutated bases
underlined) CTGAGGGACCCTGTGATTTCAGGACTCAACACC (forward)
and GGTGTTGAGTCCTGAAATCACAGGGTCCCTCAG (reverse). Human
synaptophysin tagged at its N-terminus with mCerulean (mCer-hSyp) was
generated as outlined previously (Gordon and Cousin, 2013). The T198I
mutant was introduced into mCer-hSyp by mutagenesis using the primers
(mutated bases underlined) TGAGAGACCCTGTGATCTCGGGACTCAACAC
(forward) and GTGTTGAGTCCCGAGATCACAGGGTCTCTCA (reverse).
SybII-mOrange2 was generated by amplifying the coding sequence of
mouse sybII (from sybII-pHluorin) using the primers ATTGTCTCGAGATG-
TCGGCTACCGCTGCCACCGTCC (forward) and CGTGTTGGATCCCGAGTG-
CTGAAGTAAACGATGATGATG (reverse, restriction sites underlined). The
sybII sequence was cloned into a mOrange2-N1 vector (Addgene, clone
number 54568) using XhoI and BamHI enzymes.
Neurobasal media, B-27 supplement, penicillin/streptomycin,
Minimal Essential Medium (MEM), and Lipofectamine 2000 were ob-
tained from Invitrogen (Paisley, UK). All other reagents were obtained
from Sigma-Aldrich (Poole, UK).
2.3. Hippocampal neuronal cultures
Synaptophysin knockout mice were maintained as heterozygous
breeding pairs on a C57/BL6J background (Gordon et al., 2011). All
animal work was performed in accordance with the UK Animal (Sci-
entiﬁc Procedures) Act 1986, under Project and Personal License au-
thority and was approved by the Animal Welfare and Ethical Review
Body at the University of Edinburgh. All animals were killed by sche-
dule 1 procedures in accordance with UK Home Oﬃce Guidelines.
Dissociated primary hippocampal enriched neuronal cultures were
prepared from E16.5-18.5 embryos from either synaptophysin knockout
or wild-type C57/BL6J mice of both sexes as outlined (Zhang et al.,
2015). Single-cell suspension of hippocampal neurons were plated at a
density of 3–5 × 104 cells/coverslip on poly-D-lysine and laminin-
coated 25 mm coverslips. Cells were transfected after 7–8 days in cul-
ture with Lipofectamine 2000 as described (Gordon and Cousin, 2013).
Cells were imaged after 13–16 days in culture.
2.4. Fluorescent imaging protocols
Hippocampal cultures were mounted in a Warner Instruments
(Hamden, CT, USA) imaging chamber with embedded parallel platinum
wires (RC-21BRFS) and placed on the stage of Zeiss (Cambridge, UK)
Axio Observer D1 inverted epiﬂuorescence microscope. Neurons
transfected with mCer vectors were visualised with a Zeiss EC Plan
Neoﬂuar 40×/1.30 oil immersion objective at 430 nm excitation,
whereas pHluorin reporters were visualised at 500 nm excitation. The
same emission collection was applied in both instances (using a 515 nm
dichroic ﬁlter and long-pass emission ﬁlter, > 520 nm). Dual colour
pHluorin and mOrange2 images were acquired on a dual camera system
and the signal ﬁltered using a double band pass excitation ﬁlter (470/
27 + 556/25) with beam splitter (490 + 575) and emission ﬁlters
512/30 and 630/98 (Zeiss). Fluorescent images were captured at 4 s
intervals using an AxioCam 506 mono digital camera (Zeiss). Cultures
were stimulated with a train of 300 action potentials delivered at 10 Hz
(100 mA, 1 ms pulse width) during which there was a continuous per-
fusion of imaging buﬀer (in mM: 119 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2,
30 D-glucose, 25 HEPES, pH 7.4 supplemented with 10 μM 6-cyano-7-
nitroquinoxaline-2,3-dione and 50 μM DL-2-Amino-5-phosphono-
pentanoic acid), and were then challenged with an alkaline imaging
buﬀer (50 mM NH4Cl substituted for 50 mM NaCl) to reveal total
pHluorin ﬂuorescence.
Surface-localised sybII-pHluorin reporter was revealed by bathing
neurons in imaging buﬀer, and then perfusing with an acidic buﬀer (2-
(N-morpholino)ethanesulfonic acid substituted for HEPES, pH 5.5) to
quench ﬂuorescence from sybII-pHluorin present on the plasma mem-
brane and retain background autoﬂuorescence. Neurons were washed
in imaging buﬀer, and then exposed to an alkaline imaging buﬀer to
reveal total sybII-pHluorin ﬂuorescence.
2.5. Data processing
Oﬄine processing was performed using Fiji is just ImageJ (Fiji)
software (Schindelin et al., 2012). Regions of interest of identical size
were placed over nerve terminals and the ﬂuorescence intensity was
monitored over time using the Time Series Analyzer plugin. Regions of
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interest were then screened using a customised Java program that al-
lows for visualisation of the ﬂuorescent responses and removal of the
data from nerve terminals that did not respond or displayed no recovery
following termination of the stimuli.
All subsequent data analyses were performed using Microsoft Excel,
Matlab (Cambridge, UK) and GraphPad Prism 6.0 (La Jolla, CA, USA)
software. The change in activity-dependent pHluorin ﬂuorescence was
calculated as ΔF/F0 and normalised to the peak during stimulation or
alkaline buﬀer perfusion, while the surface fraction of sybII-pHluorin
expressed as a percentage of total pHluorin was calculated using the
following equation: [(basal ﬂuorescence− acidic ﬂuorescence)/(alka-
line ﬂuorescence− acidic ﬂuorescence)] × 100.
The distribution of sybII-pHluorin ﬂuorescence along axons was
determined by calculating the coeﬃcient of variation (CV), which was
measured while neurons were exposed to alkaline imaging buﬀer to
reveal total pHluorin ﬂuorescence. The standard deviation/mean
ﬂuorescence intensity (CV) was calculated from a line proﬁle along
axon segments expressing pHluorin reporters. The mean of 5 dif-
ferent> 100 pixel axonal segments on a single coverslip was calculated
for each experiment.
Dual colour data was analysed by ﬁrst calculating ΔF/F0 values and
correcting for photobleaching using a single exponential function. The
data was then analysed as described above for sybII-pHluorin/-mOr2.
Alternatively, to examine the responses of sybII-mOr2 and syp-pHluorin
in individual nerve terminals, ﬂuorescent traces from single regions of
interest were normalised to the stimulation peak prior to ﬁltering and
removal of non-responding nerve terminals. The ﬁrst 10 frames of
decay following stimulation were then ﬁt to a linear function to obtain
the initial slope for each ﬂuorescent trace post-stimulation. In addition,
the mean value of the ﬁnal 5 frames (184–200 s) for each nerve term-
inal was determined to calculate the fraction remaining on the surface
at the end of the experiment. The sybII-mOr2 responses were then
plotted against the corresponding syp-pHluorin response from each
nerve terminal and ﬁt to a linear function to examine the relationship
between the kinetics of sybII-mOr2 and syp-pHluorin retrieval.
2.6. Statistical analysis
All statistical analysis was performed in Graph Pad Prism 6.0. A one-
way ANOVA with Tukey's post-test were used to compare more than
two groups, while a repeated measures two-way ANOVA with Tukey's
multiple-comparison post-test was performed to compare multiple
groups over time. Unless stated otherwise, the sample size (n) was taken
to be the number of independent experiments or individual coverslips.
All data are presented as mean values ± standard error of the mean
(SEM).
3. Results
3.1. Case report
A boy was born after a full term pregnancy with evident micropenis
and cryptorchidism. At the age of seven months hypogonadotropic
hypogonadism was diagnosed and he was referred to a child neurologist
because of hypotonia, restless movements and lack of visual awareness.
An MRI scan revealed complete agenesis of the corpus callosum. In the
suspicion of a Kallmann-like syndrome and Prader-Willi syndrome,
genetic analysis was performed, but did not conﬁrm any of these syn-
dromes. At the age of 1.5 years he developed generalised seizures with
focal EEG abnormalities, which were well controlled by valproate
therapy. His neuromotor development remained strongly delayed, at
the age of 9 years he did not reach the ability to stand or walk, he
developed scoliosis, divergent strabism and feedings diﬃculties. Whole
exome sequencing revealed a maternally inherited missense change in
SYP, leading to an amino acid substitution, p.Thr198Ile (here abbre-
viated as T198I).
3.2. Neurons expressing hSypT198I display normal SV recycling
The T198I mutation resides juxtaposed to the fourth transmembrane
domain in synaptophysin (Fig. 1A). Recent structural studies have
identiﬁed this region as potentially important for sybII binding (Adams
et al., 2015), suggesting this mutant may display dysfunctional sybII
retrieval. To determine this, a series of genetically-encoded ﬂuorescent
reporters of SV cargo traﬃcking were expressed in primary cultures of
hippocampal neurons derived from synaptophysin knockout mice.
These reporters are termed pHluorins, and are comprised of an exo-
genously-expressed SV cargo with a pH-sensitive EGFP moiety fused to
a lumenal domain (Kavalali and Jorgensen, 2014). The ﬂuorescence of
these reporters is quenched in the acidic environment of the SV,
whereas it is unquenched in neutral environments such as the plasma
membrane. This allows both static measurement of the distribution of
SV cargo at diﬀerent synaptic compartments and an accurate method to
track their activity-dependent movement, since ﬂuorescence is un-
quenched on SV fusion and quenched on retrieval and SV acidiﬁcation.
Since SV endocytosis is rate limiting when compared to SV acidiﬁca-
tion, ﬂuorescence quenching can be used as an estimate of the speed of
SV cargo retrieval (Atluri and Ryan, 2006; Egashira et al., 2015;
Granseth et al., 2006).
We ﬁrst examined whether the T198I mutation impacted on the
targeting of synaptophysin to nerve terminals using synaptophysin-
pHluorin (syp-pHluorin). To quantify this parameter, the coeﬃcient of
variation (CV) was analysed. CV quantiﬁes protein localisation, with a
lower CV indicating a homogeneous expression along the axon, and a
higher CV signifying a more punctate distribution (Lyles et al., 2006),
such as at nerve terminals. When this analysis was performed, the CV of
sypT198I-pHluorin showed no signiﬁcant diﬀerence to that of sypWT-
pHluorin (Fig. 1B–D) indicating the T198I mutation did not interfere
with the ability of synaptophysin to be eﬃciently targeted to nerve
terminals. We next examined whether this mutation altered the ac-
tivity-dependent traﬃcking of synaptophysin. Synaptophysin knockout
cultures expressing either sypWT-pHluorin or sypT198I-pHluorin were
challenged with a train of 300 action potentials delivered at 10 Hz. The
sypWT-pHluorin reporter displayed a characteristic response, with an
increase in ﬂuorescence during stimulation corresponding to SV fusion
(Fig. 2A, B). Following termination of the stimulus the ﬂuorescent re-
sponse of sypWT-pHluorin rapidly decreased, representative of the ki-
netics of synaptophysin retrieval. When the activity-dependent sypT198I-
Fig. 1. The T198I mutation does not impact on synaptophysin localisation. (A) Schematic
of the structure of synaptophysin with the location of the T198I mutation indicated by an
arrow. (B–D) Primary cultures of hippocampal neurons derived from synaptophysin
knockout mice were transfected with either wild-type (WT) or T198I mutant synapto-
physin-pHluorin (Syp-pH). Representative images of neurons transfected with either
sypWT-pHluorin (B) or sypT198I-pHluorin (C) are displayed, which have been pseudo-co-
loured to indicate regions of high intensity in white. Scale bar equivalent to 10 μm. (D)
Coeﬃcient of variation (CV) analysis for either sypWT-pHluorin (Black) or sypT198I-
pHluorin (red) is displayed± SEM (WT n= 12, T198I n= 8; students t-test p= 0.92).
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pHluorin response was assessed, there was no signiﬁcant diﬀerence
when compared to sypWT-pHluorin (Fig. 2B). Thus the T198I mutation
does not impact on the nerve terminal targeting or activity-dependent
traﬃcking of synaptophysin.
The absence of eﬀect of the T198I mutation on synaptophysin
traﬃcking also suggests that SV endocytosis is unaﬀected by expression
of this variant, since if this were the case the post-stimulation ﬂuor-
escent decay of the sypT198I-pHluorin response would have been mod-
iﬁed. To conﬁrm this, we examined the traﬃcking of a diﬀerent SV
cargo, the vesicular glutamate transporter, vGLUT1 (Voglmaier et al.,
2006). Synaptophysin knockout neurons were co-transfected with
vGLUT1-pHluorin and either mCer-hSypWT, mCer-hSypT198I or mCer
empty vector and challenged with a train of 300 action potentials as
before. The absence of synaptophysin had no signiﬁcant eﬀect on the
retrieval of vGLUT1-pHluorin, as evidenced by the similarity of ﬂuor-
escent responses in neurons expressing either mCer-hSypWT or the
empty mCer vector (Fig. 2A, C). Expression of mCer-hSypT198I did not
aﬀect the vGLUT1-pHluorin response when compared to neurons ex-
pressing either mCer-hSypWT or the empty mCer vector (Fig. 2C).
Therefore the T198I mutation does not perturb SV endocytosis.
3.3. Neurons expressing hSypT198I display a selective deﬁcit in activity-
dependent sybII traﬃc
The absence of synaptophysin causes a mislocalisation of its inter-
action partner sybII from nerve terminals with both endogenous and
exogenous sybII displaying a diﬀuse axonal distribution (Gordon and
Cousin, 2013; Gordon et al., 2011). Therefore we next determined
whether replacing endogenous synaptophysin with the T198I mutant
impacted on the targeting of sybII-pHluorin to synaptophysin knockout
nerve terminals. As observed previously, there was a signiﬁcant loss of
sybII-pHluorin ﬂuorescence from nerve terminals expressing the empty
mCer vector when quantiﬁed by CV (Fig. 3A, (Gordon and Cousin,
2013; Gordon et al., 2011)). In contrast neurons expressing mCer-
hSypWT displayed a more punctate distribution and a signiﬁcantly
higher CV value (Fig. 3A, B). When neurons expressing mCer-hSypT198I
were examined, sybII-pHluorin was targeted in an equivalent manner to
those expressing mCer-hSypWT (Fig. 3A, B). Therefore the T198I mu-
tation in synaptophysin does not impact on the presynaptic targeting of
sybII.
The principal presynaptic deﬁcit in the absence of synaptophysin is
aberrant retrieval of sybII from the plasma membrane during SV en-
docytosis (Gordon and Cousin, 2013; Gordon et al., 2011). This is
usually reﬂected by an increased presence of sybII-pHluorin at the
presynaptic plasma membrane and a retardation of its activity-depen-
dent retrieval. To determine whether the T198I mutation impacts on
sybII retrieval, we ﬁrst examined the eﬀect of replacing endogenous
synaptophysin with mCer-hSypT198I on the plasma membrane expres-
sion of sybII-pHluorin. This was determined by application of an im-
permeant acidic buﬀer to quench sybII-pHluorin exposed to the extra-
cellular space. This plasma membrane fraction was expressed as a
proportion of total sybII-pHluorin, which was revealed by dequenching
all ﬂuorescence with an ammonium chloride solution. The absence of
synaptophysin resulted in the stranding of sybII-pHluorin at the cell
surface when compared to rescue with mCer-hSypWT (Fig. 3A, C), as
observed previously (Gordon et al., 2011). Expression of mCer-
hSypT198I fully rescued sybII-pHluorin surface expression in synapto-
physin knockout neurons (Fig. 3A, C), indicating that there is no loca-
lisation deﬁcit in the presence of this mutant in resting neurons.
To determine whether the activity-dependent traﬃcking of sybII-
pHluorin was aﬀected by this mutation, synaptophysin knockout neu-
rons expressing either mCer-hSypWT, mCer-hSypT198I or mCer empty
vector were challenged with a train of 300 action potentials. The ab-
sence of synaptophysin resulted in a slowing of the retrieval of sybII-
pHluorin when compared to rescue with mCer-hSypWT (Fig. 4A, B), as
observed previously (Gordon and Cousin, 2013; Gordon et al., 2011).
Fig. 2. The T198I mutation does not impact on synaptic
vesicle endocytosis. Primary cultures of hippocampal neu-
rons derived from synaptophysin knockout mice were
transfected with either (A, B) wild-type (WT) or T198I
mutant synaptophysin-pHluorin (Syp-pH) or (A, C)
vGLUT1-pHluorin and either wild-type mCerulean-tagged
human synaptophysin (WT), the T198I mutant (T198I) or
empty mCer vector (KO). Neurons were then challenged
with a train of 300 action potentials delivered at 10 Hz
before perfusing buﬀer containing NH4Cl. (A) Pseudo-co-
loured images from a representative time-lapse are shown
prior to the stimulus (t = 0 s), during the stimulus
(t = 44 s), following endocytosis (t = 200 s) and during
de-quenching of the vesicular pool of pHluorin by NH4Cl.
Images have been pseudo-coloured to indicate regions of
high intensity in white. Scale bar equivalent to 10 μm. (B)
SypWT-pHluorin (black) or sypT198I-pHluorin (red) traces
display the average ﬂuorescent syp-pHluorin response
normalised to the peak of stimulation (ΔF/F0 ± SEM, WT
n= 12, T198I n= 8). (C) The average ﬂuorescent
vGLUT1-pHluorin response normalised to the peak of sti-
mulation (ΔF/F0 ± SEM) is displayed for neurons expres-
sing mCer-hSypWT (black), mCer-hSypT198I (red) or mCer
(KO, blue). WT n= 9, T198I n= 8, KO n= 15. In both
cases the bar indicates the period of stimulation. A two-way
ANOVA was performed and no signiﬁcant diﬀerence was
observed between the traces.
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Intriguingly mCer-hSypT198I did not rescue sybII-pHluorin retrieval ki-
netics, instead sybII-pHluorin retrieval appeared very similar to that
observed in the absence of synaptophysin (Fig. 4A, B). This was not due
to a change in the number of SVs fusing by exocytosis, since the pro-
portion of sybII-pHluorin undergoing exocytosis was unchanged when
normalised to the total sybII-pHluorin pool (Fig. 5A, B). This was also
the case for syp-pHluorin and vGLUT1-pHluorin (Fig. 5B). Thus there is
a speciﬁc, activity-dependent deﬁcit in sybII retrieval when endogenous
synaptophysin is replaced by the T198I synaptophysin mutant.
To determine whether this activity-dependent defect in sybII traﬃc
observed with the T198I mutant was due to loss of synaptophysin
function, we expressed mCer-hSypT198I in wild-type neurons to de-
termine whether it had any dominant negative eﬀect. There was no
diﬀerence in activity-dependent sybII-pHluorin traﬃcking in cells ex-
pressing mCer-hSypT198I when compared to those expressing mCer-
hSypWT (Fig. 4C), therefore the T198I mutation is a loss of function
mutation.
To conﬁrm that the T198I mutation speciﬁcally impacts sybII re-
trieval without altering synaptophysin traﬃcking, we next examined
the traﬃcking of synaptophysin and sybII using dual colour imaging.
This approach monitors the activity-dependent retrieval of both syp-
pHluorin and sybII fused to the pH-sensitive dsRed variant mOrange2
(mOr2) (Shaner et al., 2008), permitting tracking of the retrieval of
both proteins within the same nerve terminals. To ﬁrst conﬁrm that
dual colour imaging accurately reﬂected cargo traﬃcking observed
using pHluorins, wild-type neurons were transfected with both sybII-
pHluorin and sybII-mOr2 (Fig. 6A). The ﬂuorescent response evoked by
a train of 300 action potentials was identical between the two ﬂuor-
escent proteins, indicating that the mOr2 response accurately reports
sybII traﬃc (Fig. 6B).
To examine the traﬃcking of sybII-mOr2 and syp-pHluorin within
the same nerve terminals, synaptophysin knockout neurons were
transfected with sybII-mOr2 and either sypWT-pHluorin or sypT198I-
pHluorin. Following normalisation of the individual nerve terminals to
the stimulation peak, the average responses of nerve terminals ex-
pressing sybII-mOr2 and either sypWT-pHluorin or sypT198I-pHluorin
were examined, with the results highly similar to those using pHluorins
(Fig. 6C, D). Speciﬁcally, there was no signiﬁcant diﬀerence between
the sypWT-pHluorin and sypT198I-pHluorin responses, whereas there was
a signiﬁcant diﬀerence between the sybII-mOr2 responses in neurons
expressing sypWT-pHluorin and those expressing sypT198I-pHluorin
(two-way ANOVA, p < 0.01).
The ﬂuorescent responses of sypWT-pHluorin and sybII-mOr2 from
the same cells showed that although each of the proteins retrieved at a
similar rate, the kinetics appeared to be distinct (Fig. 6C, D). We
therefore determined whether the retrieval kinetics of synaptophysin
and sybII showed a correlation at the level of individual nerve term-
inals. We ﬁrst examined the rate of cargo retrieval in each nerve
terminal by calculating the initial decay in ﬂuorescence during the ﬁrst
40 s following stimulation using a linear function. There was a good
Fig. 3. The T198I mutation has no eﬀect on sybII locali-
sation or surface fraction. Primary cultures of synapto-
physin knockout hippocampal neurons were transfected
with sybII-pHluorin and either wild-type mCerulean-tagged
human synaptophysin (WT), the T198I mutant (T198I) or
empty mCer vector (KO). (A) Representative images of
neurons transfected with sybII-pHluorin are displayed. The
images have been pseudo-coloured to indicate regions of
high intensity in white. Scale bar equivalent to 10 μm. (B)
Coeﬃcient of variation (CV) analysis for sybII-pHluorin is
displayed for neurons co-expressing either WT (black),
T198I (red) or mCer (KO, blue) ± SEM (WT n= 11, T198I
n= 14, KO n= 18). ** = p < 0.01, * = p < 0.05,
** = p < 0.01, one-way ANOVA against WT. (C) Surface
expression of sybII-pHluorin is displayed as a percentage of
total sybII-pHluorin for neurons co-expressing WT (black),
T198I (red) and mCer (KO, blue) ± SEM (WT n= 11,
T198I n= 14, KO n= 18). *** = p < 0.001, one-way
ANOVA against WT.
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correlation between the initial retrieval kinetics of sybII-mOr2 when
compared to sypWT-pHluorin (Fig. 6E). No change in this relationship
was detected when compared to that of sybII-mOr2 and sypT198I-
pHluorin. This indicates that within individual nerve terminals the rate
of sybII retrieval is unaltered by the T198I mutation.
We next determined whether the capacity of individual nerve
terminals to retrieve sybII was impacted by the synaptophysin T198I
mutation. We examined whether the fraction of sybII and synapto-
physin stranded on the plasma membrane after action potential sti-
mulation was correlated across individual nerve terminals. This
analysis demonstrated that nerve terminals that eﬃciently cleared
sypWT-pHluorin from the plasma membrane also did so for sybII-mOr2.
This relationship was again unchanged when sypT198I-pH was ex-
pressed, however increased sybII-mOr2 stranding was observed as
evidenced by a signiﬁcant increase in the Y-intercept value (Fig. 6F).
This result indicates that nerve terminals expressing the synaptophysin
T198I mutant display a decreased capacity for sybII retrieval, while
retaining a close correlation in the proportional extent of retrieval.
Fig. 4. The T198I mutation selectively impacts on activity-
dependent sybII retrieval during SV endocytosis. (A, B)
Primary cultures of synaptophysin knockout hippocampal
neurons were transfected with sybII-pHluorin and either
wild-type mCerulean-tagged human synaptophysin (WT),
the T198I mutant or empty mCer vector (KO) and chal-
lenged with a train of 300 action potentials (10 Hz) before
being allowed to recover and exposed to a NH4Cl con-
taining buﬀer. (A) Pseudo-coloured images from a re-
presentative time-lapse are shown prior to the stimulus
(t = 0 s), during the stimulus (t = 44 s), following en-
docytosis (t = 200 s) and during perfusion of NH4Cl. Scale
bar equivalent to 10 μm. (B) Traces (WT, black; T198I, red;
KO, blue) display the average ﬂuorescent sybII-pHluorin
response normalised to the peak of stimulation (ΔF/
F0 ± SEM). Stimulation is indicated by the bar. WT n= 9,
T198I n= 14, mCer n= 13, * = p < 0.05 for both T198I
and KO compared to WT, two-way ANOVA. (C) Wild-type
hippocampal neurons transfected with sybII-pHluorin and
either WT (black) or T198I (red) mCerulean-tagged human
synaptophysin were challenged with a train of 300 action
potentials (10 Hz) as indicated by the bar. Traces display
the average ﬂuorescent sybII-pHluorin response normalised
to the peak of stimulation (ΔF/F0 ± SEM). WT n= 11,
T198I n= 10, ns, two-way ANOVA.
Fig. 5. The T198I mutation has no eﬀect on SV exocytosis.
Primary cultures of synaptophysin knockout hippocampal
neurons were transfected with either WT (black) or T198I
(red) syp-pHluorin (B) or co-transfected with sybII-
pHluorin (A, B) or vGLUT1-pH (B) and wild-type
mCerulean-tagged human synaptophysin (WT, black) or the
T198I mutant (T198I, red). Neurons were challenged with a
train of 300 action potentials (10 Hz) and after 3 min a
pulse of a buﬀer containing 50 mM NH4Cl to unquench all
pHluorin ﬂuorescence was applied as indicated by bars. (A)
Traces display the average ﬂuorescent sybII-pHluorin re-
sponse normalised to the total pool (ΔF/F0 (NH4) ± SEM).
(B) The average peak height of sybII-pHluorin (sybII),
vGLUT1-pHluorin (vGLUT1) or syp-pHluorin (syp) nor-
malised to NH4Cl (ΔF/F0 (NH4) ± SEM) is displayed
(sybII-pH; WT n= 9, T198I n= 14, vGLUT-pH; WT n= 9,
T198I n= 8, syp-pH WT n= 12, T198I n= 8; all ns stu-
dents t-test).
C.B. Harper et al. Neurobiology of Disease 108 (2017) 298–306
303
3.4. Neurons expressing hSyp mutants impact sybII surface stranding to
diﬀering extents
The speciﬁc eﬀect of the T198I synaptophysin mutant on activity-
dependent sybII traﬃcking but not cell surface expression was unusual,
since the latter parameter is usually the result of a perturbation in cargo
retrieval. To determine whether this was a common consequence of
synaptophysin dysfunction, we determined the eﬀect of a series of sy-
naptophysin mutations identiﬁed in patients with X-linked intellectual
disability (Tarpey et al., 2009) on sybII surface expression. Two of these
mutants result in the truncation of synaptophysin (59* and 136*), and
replacement of the endogenous protein with these mutants could not
rescue activity-dependent sybII-pHluorin retrieval (Gordon and Cousin,
2013). Replacement with the other mutants (a point mutation in the 4th
transmembrane domain (G217R) and frame shift in the C-terminus,
469 fs) supported a partial recovery of sybII-pHluorin retrieval (Gordon
and Cousin, 2013). We ﬁrst conﬁrmed the eﬀect of these mutants on
sybII-pHluorin targeting. We found that the truncation mutants mCer-
hSyp59⁎ and mCer-hSyp136⁎ did not rescue sybII-targeting, mCer-
hSypG217R displayed an intermediate rescue and mCer-hSyp469fs fully
rescued, in agreement with previous results (Fig. 7B) (Gordon and
Cousin, 2013). When sybII-pHluorin plasma membrane stranding was
evaluated, a complex picture emerged. The truncation mutants mCer-
hSyp59⁎ and mCer-hSyp136⁎ did not rescue surface stranding over that
observed in the absence of synaptophysin. Contrary to its ability to
target sybII to nerve terminals, mCer-hSypG217R was also unable to
rescue surface stranding of sybII. Conversely, mCer-hSyp469fs fully
rescued sybII-pHluorin surface expression to wild-type levels. Thus
defects in activity-dependent sybII traﬃcking do not necessarily
translate into plasma membrane stranding or mislocalisation of sybII
along the axon.
4. Discussion
A novel mutation in the SYP gene was identiﬁed in a male patient
with severe ID, hypotonia, epilepsy, hypogonadotropic hypogonadism
Fig. 6. Dual colour imaging of synaptophysin and sybII
traﬃcking during SV endocytosis. (A, B) Primary cultures
of wild-type hippocampal neurons were transfected with
sybII-mOrange2 (sybII-mOr2) and sybII-pHluorin (sybII-
pH). (A) Images display the ﬂuorescence of either sybII-
pHluorin (pH, green), sybII-mOr2 (mOr2, red) or a merged
image. Scale bar equivalent to 10 μm. (B) Neurons co-ex-
pressing sybII-pHluorin and sybII-mOr2 were challenged
with a train of 300 action potentials (10 Hz). SybII-mOr2
(orange) and sybII-pHluorin (green) traces display the
average ﬂuorescent response normalised to the peak of
stimulation (ΔF/F0 ± SEM, both n= 8). Bar indicates the
period of stimulation. (C, D) Synaptophysin knockout hip-
pocampal neurons were transfected with sybII-mOr2 and
either wild-type (WT) or T198I mutant synaptophysin-
pHluorin (Syp-pH) and challenged with a train of 300 ac-
tion potentials (10 Hz). SybII-mOr2 (orange),
sypWT–pHluorin (green) and sypT198I–pHluorin (red) traces
display the average ﬂuorescent response of each nerve
terminal normalised to the peak of stimulation (ΔF/
F0 ± SEM). Bar indicates period of stimulation (WT
n= 13, T198I n= 15). * = p < 0.05 for sybII-mOr2 re-
sponse when comparing WT and T198I expressing neurons,
two-way ANOVA. (E) The rate of decay of sybII-mOr2
ﬂuorescence during the ﬁrst 10 frames following stimula-
tion was plotted against the corresponding syp–pHluorin
values and ﬁt to a linear function (WT, black r2 = 0.134;
n= 697, T198I, red r2 = 0.099; n= 700). No signiﬁcant
diﬀerence in either slope (0.4447 (WT) vs. 0.3479 (T198I))
or Y-intercept (−0.0045 (WT) vs. −0.0050 (T198I)) was
observed between sybII values in relation to sypWT and
sypT198I (F) The fraction of sybII-mOr2 remaining on the
plasma membrane 150 s following stimulation was plotted
against the corresponding syp-pHluorin values and ﬁt to a
linear function (WT, black r2 = 0.062; n= 697, T198I, red
r2 = 0.036; n= 700). While no diﬀerence was observed in
the slope (0.304 (WT) vs. 0.252 (T198I)), the Y-intercept
was signiﬁcantly higher (0.155 (WT) vs. 0.261 (T198I))
(p < 0.0001) for sybII-mOr2 when expressed with
sypT198I-pHluorin, indicating increased surface stranding of
sybII-mOr2.
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and callosal agenesis. The combination of problems in our patient dif-
fers from the previously reported patients, because hypogonadism, se-
vere hypotonia and callosal agenesis have not been previously de-
scribed and deﬁne a recognisable, syndromic type of X-linked
intellectual disability (Tarpey et al., 2009). When this mutant was ex-
pressed in a knockout system, it did not impact on synaptophysin
traﬃcking or SV endocytosis. It did however have a selective eﬀect on
the activity-dependent retrieval of its interaction partner sybII, but not
on sybII targeting to nerve terminals or plasma membrane levels. This
mutation has revealed that synaptophysin-dependent control of ac-
tivity-dependent sybII traﬃc can be decoupled from changes in sybII
localisation and suggests that synaptophysin control of sybII traﬃcking
may involve multiple mechanisms.
In addition to a selective eﬀect on sybII traﬃcking, synaptophysin
knockout neurons display a minor slowing in the kinetics of SV en-
docytosis (Kwon and Chapman, 2011; Rajappa et al., 2016). In previous
studies we have also observed this phenomenon, however it did not
impact on the number of SVs retrieved during an action potential train
(Gordon et al., 2011). In this study we also observed a slight slowing in
SV endocytosis, measured using vGLUT1-pH, both in the absence of
synaptophysin and in the presence of the T198I mutant, however in
both cases it did not reach signiﬁcance (Time constant (τ) WT
41.4 ± 4.3 s n= 9; mCer 52.7 ± 5.3 s n= 15; T198I 63.4 ± 13.3 s
n= 8; not signiﬁcant one-way ANOVA). A recent study has suggested
that this slowing defect is activity-dependent, with the absence of sy-
naptophysin having little impact with mild stimuli (Rajappa et al.,
2016). This slowing is not a secondary consequence of perturbed sybII
retrieval, since normal SV endocytosis kinetics can be observed during
dysfunctional sybII retrieval (Gordon and Cousin, 2013). Therefore the
physiological relevance of this kinetic eﬀect is still unclear.
Mistargeting to the plasma membrane is often a consequence of
retarded SV cargo retrieval. However the human synaptophysin muta-
tions examined in this work reveal that these events can be uncoupled.
Both the T198I and 469 fs synaptophysin mutants were able to fully
rescue surface stranding and localisation of sybII while still displaying
an activity-dependent defect in retrieval. The most parsimonious reason
for these discrepancies in traﬃcking and localisation is that sybII is
retrieved in the presence of the mutant albeit with slower kinetics.
Therefore surface stranding may only be apparent transiently following
prolonged stimulation.
The lack of correlation between retarded retrieval and plasma
membrane localisation of SV proteins has also been observed for a
diﬀerent SV cargo, synaptotagmin-1. Synaptotagmin-1 displayed ac-
celerated activity-dependent retrieval in parallel with an increased
expression at the plasma membrane when its monomeric adaptor
stonin-2 or SV interaction partner SV2A were depleted from neurons
(Kaempf et al., 2015; Kononenko et al., 2013; Zhang et al., 2015).
Mutations such as the T198I mutation may therefore be highly in-
formative in assembling a comprehensive picture of the relationship
between activity-dependent SV cargo retrieval and cell surface fraction.
The correlation between synaptophysin and sybII retrieval within
nerve terminals suggests that the two proteins are traﬃcked through
the same pathway. What is of interest is that this correlation between
sybII and synaptophysin retrieval was retained with the T198I muta-
tion, even though less sybII was retrieved relative to synaptophysin at
individual nerve terminals. This suggests that parallel mechanisms may
be present to recover sybII from the plasma membrane even in the
potential disruption of its interaction with synaptophysin (Koo et al.,
2015; Koo et al., 2011). The interaction between synaptophysin and
sybII has been identiﬁed for many years (Calakos and Scheller, 1994;
Edelmann et al., 1995; Washbourne et al., 1995), however little deﬁ-
nitive information is present relating to exactly where the interaction
occurs. Previous work involving in vitro and in vivo truncation studies
suggests that sybII interacts with synaptophysin via its transmembrane
domain and ﬂanking N-terminal sequence (Felkl and Leube, 2008;
Reisinger et al., 2004; Yelamanchili et al., 2005). Synaptophysin may
also interact with sybII via its transmembrane domains, since removal
of its cytoplasmic C-terminus does not impact on sybII binding
(Bonanomi et al., 2007; Felkl and Leube, 2008). Recent structural stu-
dies have suggested that the 4th transmembrane domain of synapto-
physin is critical for the sybII interaction. (Adams et al., 2015). The
previously identiﬁed G217R mutation may disrupt this interaction since
it is predicted to disrupt a transmembrane binding pocket for the
transmembrane domain of sybII (Adams et al., 2015). Since T198I
mutation is juxtaposed to 4th transmembrane domain in the SV lumen
it may have a similar eﬀect on sybII binding. However the divergence in
their eﬀect on sybII plasma membrane stranding suggest that a simple
loss of sybII interaction cannot be solely responsible for their eﬀects on
sybII traﬃcking.
SYP is an X-linked gene making the male patient hemizygous for this
mutation, therefore our molecular replacement strategy is re-
presentative of the clinical condition. How could such a profound defect
Fig. 7. Eﬀect of multiple XLID synaptophysin mutations on
sybII targeting and surface fraction. (A, B) Primary cultures
of synaptophysin knockout hippocampal neurons were
transfected with sybII-pHluorin and either wild-type
mCerulean-tagged human synaptophysin (WT, black),
truncation mutants (59*, purple and 136*, maroon) a point
mutant (G217R, orange), a frame shift mutant (469 fs,
green) or empty mCer vector (mCer, red). (A) Coeﬃcient of
variation (CV) analysis for sybII-pHluorin is
displayed± SEM (mCer n= 12, WT n= 11, 59* n= 13,
136* n= 13, G217R n= 10, 469 fs n= 12).
*** = p < 0.001, * = p < 0.05 one-way ANOVA com-
pared to WT, ### = p < 0.001, # = p < 0.05 one-way
ANOVA compared to mCer. (B) Surface expression of sybII-
pHluorin is displayed as a percentage of total± SEM (mCer
n= 12, WT n= 11, 59* n= 13, 136* n= 13, G217R
n= 10, 469 fs n= 12, KO n= 12). *** = p < 0.001,
* = p < 0.05 one-way ANOVA compared to WT,
# = p < 0.05 one-way ANOVA compared to mCer.
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in the traﬃcking of a key cargo molecule such as sybII result in the
survival of an individual carrying this mutation, albeit with a severe
neurodevelopmental disorder? Firstly there is a large excess of sybII on
SVs. There are approximately 70 copies of sybII on an average SV
(Takamori et al., 2006; Wilhelm et al., 2014) whereas only between one
to three copies are essential for SV fusion (Mohrmann et al., 2010;
Sinha et al., 2011; van den Bogaart et al., 2010). One would therefore
predict that this activity-dependent defect in sybII retrieval would only
impact on neurotransmission during repeated bursts of intense activity.
In support, we have observed a decrease in presynaptic performance
during repeated patterns of activity in synaptophysin knockout neurons
(unpublished observations). Given that the localisation of sybII is un-
changed in resting neurons, the T198I mutation may only impact on a
speciﬁc subset of neurons that ﬁre at suﬃcient frequencies to render
them susceptible to dysfunctional sybII retrieval. In support, defective
sybII retrieval was more pronounced in inhibitory neurons from mice
where the speciﬁc sybII adaptor AP180 was deleted (Koo et al., 2015).
Importantly, these mice showed a greater impairment in hippocampal
inhibitory neurotransmission, resulting in inhibitory/excitatory im-
balance, an outcome that has been linked to several neurodevelop-
mental disorders (Koo et al., 2015). It is possible therefore that the
impaired sybII retrieval observed with this synaptophysin mutation
results in a similar defect. Therefore the identiﬁcation of activity pat-
terns that render key neurons and circuits susceptible to speciﬁc pre-
synaptic mutations may be central to understanding the genesis of
speciﬁc neurodevelopmental disorders.
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